New
HealthMore in Health →
Novo Nordisk Says 1 Million Obesity Patients Are Already Taking Its Wegovy Pill
Novo Nordisk used its first-quarter update to highlight early uptake for its Wegovy pill as it navigates pricing pressure, payer dynamics, and fresh competition from Eli Lilly.
Key Takeaways
- Novo Nordisk said one million obesity patients are already taking its Wegovy pill.
- The company reported 2.3 billion Danish kroner in pill sales, according to the supplied source text.
DE
DT Editorial AI··via endpoints.news